General Information of Disease (ID: DISFHG81)

Disease Name Partial trisomy of the long arm of chromosome 5
Synonyms
5q duplication; partial trisomy 5q; chromosome 5q duplication; Duplication 5q; trisomy 5q; 5q trisomy; partial duplication of chromosome 5q; partial trisomy of chromosome 5q; partial duplication of the long arm of chromosome 5; partial trisomy of the long arm of chromosome type 5
Definition
Chromosome 5q duplication is a chromosome abnormality that occurs when there is an extra copy of genetic material on the long arm (q) of chromosome 5. The severity of the condition and the signs and symptoms depend on the size and location of the duplication and which genes are involved. Features that often occur in people with chromosome 5q duplication include developmental delay, intellectual disability, behavioral problems and distinctive facial features. Chromosome 5q duplication can be de novo or inherited from a parent with a chromosomal rearrangement such as a balanced translocation. Treatment is based on the signs and symptoms present in each person.
Disease Hierarchy
DISPKU5I: Syndrome caused by partial chromosomal duplication
:
DISFHG81: Partial trisomy of the long arm of chromosome 5
Disease Identifiers
MONDO ID
MONDO_0016956
MESH ID
C537650
UMLS CUI
C1802398
MedGen ID
315659
Orphanet ID
262869

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 6 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CSNK1A1 TTFQEMX moderate Altered Expression [1]
LARP1 TTSN1YP moderate Altered Expression [2]
CD74 TTCMYP9 Strong Genetic Variation [3]
CSF1R TT7MRDV Strong Genetic Variation [4]
FGF1 TTMY81X Strong Biomarker [5]
GLRA1 TTF45NW Strong Biomarker [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DTT(s)
This Disease Is Related to 6 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ATOX1 OT05LF59 moderate Biomarker [7]
KLF1 OT1FK08U moderate Altered Expression [8]
SH3TC2 OTJ6XY2A moderate Genetic Variation [6]
MSX2 OT1WDKE1 Strong Biomarker [9]
RARS1 OTHPZ6JN Strong Biomarker [10]
RPS14 OTB90KV5 Strong Biomarker [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DOT(s)

References

1 Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome.Leukemia. 2019 Jul;33(7):1759-1772. doi: 10.1038/s41375-018-0350-3. Epub 2019 Jan 16.
2 Autogenous Control of 5TOP mRNA Stability by 40S Ribosomes.Mol Cell. 2017 Jul 6;67(1):55-70.e4. doi: 10.1016/j.molcel.2017.06.005. Epub 2017 Jun 29.
3 5q- syndrome.Curr Pharm Des. 2012;18(22):3180-3. doi: 10.2174/1381612811209023180.
4 Allelic loss of the FMS gene in acute myeloid leukaemia.Leuk Res. 1997 Oct;21(10):919-23. doi: 10.1016/s0145-2126(97)00024-6.
5 Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.Genes Chromosomes Cancer. 1998 Jul;22(3):251-6. doi: 10.1002/(sici)1098-2264(199807)22:3<251::aid-gcc11>3.0.co;2-r.
6 Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.Haematologica. 2008 Jul;93(7):994-1000. doi: 10.3324/haematol.12603. Epub 2008 May 27.
7 Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene.Hum Genet. 2000 Jan;106(1):127-9. doi: 10.1007/s004399900215.
8 Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.Ann Hematol. 2013 Jan;92(1):11-8. doi: 10.1007/s00277-012-1568-1. Epub 2012 Sep 11.
9 Bilateral radial agenesis with absent thumbs, complex heart defect, short stature, and facial dysmorphism in a patient with pure distal microduplication of 5q35.2-5q35.3.BMC Med Genet. 2013 Jan 24;14:13. doi: 10.1186/1471-2350-14-13.
10 Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.Leuk Res. 2008 Jan;32(1):33-7. doi: 10.1016/j.leukres.2007.02.021. Epub 2007 Apr 6.